Malaysia Clinical Laboratory Services Market
Tamanho do mercado em biliões de dólares
CAGR :
% 
USD
2,006.35 Million
USD
3,130.48 Million
2020
2028
 Período de previsão |
2021 –2028 |
 Tamanho do mercado (ano base ) | USD 2,006.35 Million |
 Tamanho do mercado ( Ano de previsão) | USD 3,130.48 Million |
 CAGR |
% |
| Principais participantes do mercado |
Malaysia Clinical Laboratory Services Market, By Service Type (Routine Testing Services, Esoteric Services, and Anatomic Pathology Services), Specialty (Clinical Chemistry Testing, Haematology Testing, Microbiology Testing, Immunology Testing, Drugs of Abuse Testing, Cytology Testing and Genetic Testing), Provider (Hospital-Based Laboratories, Independent and Reference Laboratories, Clinical-Based Laboratories, and Nursing and Physician Office-Based Laboratories), Application (Bioanalytical and Lab Chemistry Services, Drug Development Related Services, Drug Discovery Related Services, Toxicology Testing Services, Cell, and Gene Therapy Related Services, Preclinical and Clinical Trial Related Services, and Other Clinical Laboratory Services), Country (Malaysia) Industry Trends and Forecast to 2028.
Market Analysis and Insights: Malaysia Clinical Laboratory Services Market
Malaysia clinical laboratory services market is expected to gain market growth in the forecast period of 2021 to 2028. Data Bridge Market Research analyses that the Malaysia clinical laboratory services market is growing with a CAGR of 5.8% in the forecast period of 2021 to 2028 and is expected to reach USD 3,130.48 million by 2028 from USD 2,006.35 million in 2020. Growing adoption for digital pathology platforms and advancement in clinical diagnostic methods are the major drivers that propelled the market's demand in the forecast period.
Clinical laboratories are an important part of the healthcare sector. Most diagnostic tests, starting from the blood test to the genetic analysis, are conducted in these clinical laboratories to detect diseases. Clinical laboratories offer data and resources that optimize the required distribution in the healthcare system, such as diagnostics and test results. This maintains and provides reliable and correct test results that enable doctors to make appropriate clinical and diagnostic decisions across various levels of health care services.
The increasing adoption of digital pathology has further propelled the demand for clinical laboratory services. The high prevalence of infectious diseases across Malaysia and the increasing awareness of early and accurate diagnosis is likely to fuel the growth of the clinical laboratory services market. Moreover, inadequate reimbursement policies act as a challenge for the market. The strategic initiatives by market players and rising preventive health check-ups act as an opportunity for the market's growth. However, inaccurate test results and stringent regulatory policies act as a restraint for its growth in the market.
Malaysia clinical laboratory services market report provides details of market share, new developments, and product pipeline analysis, the impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, product approvals, strategic decisions, product launches, geographic expansions, and technological innovations in the market. To understand the analysis and the market scenario, contact us for an Analyst Brief; our team will help you create a revenue impact solution to achieve your desired goal.
Malaysia Clinical Laboratory Services Market Scope and Market Size
Malaysia clinical laboratory services market is segmented based on service type, specialty, provider, and application. The growth among segments helps you analyse niche pockets of growth and strategies to approach the market and determine your core application areas and the difference in your target markets.
- On the basis of service type, the Malaysia clinical laboratory services market is segmented into routine testing services, esoteric services, and anatomic pathology services. In 2021, the routine testing services segment is expected to dominate the market due to the rising awareness of early and accurate diagnosis.
- On the basis of specialty, the Malaysia clinical laboratory services market is segmented into clinical chemistry testing, microbiology testing, haematology testing, genetic testing, drugs of abuse testing, and immunology testing. In 2021, the clinical chemistry testing segment is expected to dominate the market due to the rise in advanced clinical diagnostic methods for accurate test results.
- On the basis of provider, the Malaysia clinical laboratory services market is segmented into independent and reference laboratories, hospital-based laboratories, and nursing and physician office-based laboratories. In 2021, the hospital-based laboratories segment is expected to dominate the market due to an increase in infectious disease cases, which leads to high patient volumes and high test demand.
- On the basis of application, the Malaysia clinical laboratory services market is segmented into drug discovery related services, drug development related services, bioanalytical and lab chemistry services, toxicology testing services, cell and gene therapy related services, preclinical and clinical trial related services, and other clinical laboratory services. In 2021, the bioanalytical and lab chemistry services segment is expected to dominate due to new variants of infectious diseases.
Rising Preference of Preventive Health Check-Ups and Increasing Strategic Initiatives by Market Players in the Market is Creating New Opportunities for Players in the Malaysia Clinical Laboratory Services Market
Malaysia clinical laboratory services market also provides you with a detailed market analysis of market sales, impact of advancement in the Malaysia clinical laboratory services market, and changes in regulatory scenarios with their support for the Malaysia clinical laboratory services market. The data is available for the historical period 2010 to 2019.
Competitive Landscape and Malaysia Clinical Laboratory Services Market Share Analysis
The Malaysia clinical laboratory services market competitive landscape provides details by the competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, production sites and facilities, company strengths and weaknesses, product launch, product trials pipelines, product approvals, patents, product width, and breadth, application dominance, technology lifeline curve. The above data points are only related to the company’s focus on the Malaysia clinical laboratory services market.
The major players covered in the Malaysia clinical laboratory services market report are Eurofins Scientific, Siemens Healthcare GmbH, Abbott, DaVita Inc., Charles River Laboratories, Laboratory Corporation of America Holdings, Sunway Med Lab, PT Kimia Farma Diagnostika, SGS SA, and Syneos Health, among others and domestic and global players. DBMR analysts understand competitive strengths and provide competitive analysis for each competitor separately.
Many product launches and agreements are also initiated by the companies that accelerate the Malaysia clinical laboratory services market.
For instances,
- In June, Eurofins Scientific announced that its subsidiary Eurofins Clinical Testing US Holdings, Inc. entered into an agreement for acquisition Diagnostics Center (“DDC”) which is aa leader in consumer genetic testing services. This Acquisition has benefitted the company in terms of expanding its testing services in consumer genetic testing.
- In February, Siemens Healthcare GmbH offered lab-based antigen test for high-throughput analyzers and expands COVID-19 test capacities. Company obtained CE Mark for its laboratory-based SARS-CoV-2 Antigen Assay (CoV2Ag); the test will be offered at the Atellica Solution and ADVIA Centaur®analyzers, widely available in laboratories worldwide.
SKU-
Obtenha acesso online ao relatório sobre a primeira nuvem de inteligência de mercado do mundo
- Painel interativo de análise de dados
- Painel de análise da empresa para oportunidades de elevado potencial de crescimento
- Acesso de analista de pesquisa para personalização e customização. consultas
- Análise da concorrência com painel interativo
- Últimas notícias, atualizações e atualizações Análise de tendências
- Aproveite o poder da análise de benchmark para um rastreio abrangente da concorrência
Índice
1 INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 OVERVIEW
1.4 LIMITATIONS
1.5 MARKETS COVERED
2 MARKET SEGMENTATION
2.1 MARKETS COVERED
2.2 GEOGRAPHICAL SCOPE
2.3 YEARS CONSIDERED FOR THE STUDY
2.4 CURRENCY AND PRICING
2.5 DBMR TRIPOD DATA VALIDATION MODEL
2.6 MULTIVARIATE MODELLING
2.7 SERVICE TYPE LIFELINE CURVE
2.8 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS
2.9 DBMR MARKET POSITION GRID
2.1 MARKET BY SERVICE TYPE COVERAGE GRID
2.11 VENDOR SHARE ANALYSIS
2.12 SECONDARY SOURCES
2.13 ASSUMPTIONS
3 EXECUTIVE SUMMARY
4 PREMIUM INSIGHTS
4.1 PESTEL ANALYSIS
4.2 PORTERS FIVE FORCES
5 MALAYSIA CLINICAL LABORATORY SERVICES MARKET CLINICAL LABORATORY SERVICES MARKET: REGULATIONS
5.1 REGULATIONS IN THAILAND
5.2 REGULATIONS IN PHILIPPINES
5.3 REGULATIONS IN MALAYSIA
5.4 REGULATION IN INDONESIA
6 REIMBURSEMENT SCENARIO
7 MARKET OVERVIEW
7.1 DRIVERS
7.1.1 RISING PREVALENCE OF INFECTIOUS DISEASES
7.1.2 ADVANCEMENTS IN CLINICAL DIAGNOSTIC METHODS
7.1.3 DEVELOPMENT IN DATABASE MANAGEMENT TOOLS AND WIDE ACCEPTANCE OF POINT-OF-CARE (POC) TESTING SOLUTIONS
7.1.4 RISING DEMAND FOR EARLY AND ACCURATE DISEASE DIAGNOSIS
7.1.5 RISING PER CAPITA INCOME
7.2 RESTRAINTS
7.2.1 LACK OF SKILLED AND CERTIFIED PROFESSIONALS
7.2.2 STRICT REGULATORY POLICIES
7.3 OPPORTUNITIES
7.3.1 GROWING ADOPTION OF DIGITAL PATHOLOGY PLATFORMS
7.3.2 RISING PREFERENCE FOR PREVENTIVE HEALTH CHECK-UPS
7.3.3 INCREASING AWARENESS ABOUT DIAGNOSIS AND TREATMENT OF THE DISEASE
7.3.4 STRATEGIC INITIATIVES BY MARKET PLAYERS
7.4 CHALLENGES
7.4.1 INACCURATE RESULTS OF TESTS
7.4.2 INADEQUATE REIMBURSEMENTS POLICIES
8 IMPACT OF COVID-19
8.1 PRICE IMPACT
8.2 IMPACT ON DEMAND
8.3 IMPACT ON SUPPLY CHAIN
8.4 STRATEGIC DECISIONS FOR MANUFACTURERS
8.5 CONCLUSION
9 MALAYSIA CLINICAL LABORATORY SERVICES MARKET, BY SERVICE TYPE
9.1 OVERVIEW
9.2 ROUTINE TESTING SERVICES
9.2.1 ROUTINE CHEMISTRY TESTING
9.2.2 ROUTINE HEMATOLOGY TESTING
9.2.3 URINALYSIS TESTING
9.2.4 SUBSTANCE ABUSE TESTING
9.2.5 OTHERS
9.3 ESOTERIC SERVICES
9.4 ANATOMIC PATHOLOGY SERVICES
9.4.1 CYTOLOGY TESTING
9.4.2 DIAGNOSTIC SURGICAL PATHOLOGY TESTING
9.4.3 AUTOPSY PATHOLOGY
9.4.4 OTHERS
10 MALAYSIA CLINICAL LABORATORY SERVICES MARKET, BY SPECIALTY
10.1 OVERVIEW
10.2 CLINICAL CHEMISTRY TESTING
10.2.1 ROUTINE CHEMISTRY TESTING
10.2.2 THERAPEUTIC DRUG MONITORING (TDM) TESTING
10.2.3 SPECIALIZED CHEMISTRY TESTING
10.2.4 OTHER CLINICAL CHEMISTRY TESTING
10.3 HEMATOLOGY TESTING
10.3.1 ROUTINE HEMATOLOGY TESTING
10.3.2 SPECIALIZED HEMATOLOGY TESTING
10.3.3 COAGULATION TESTING
10.4 MICROBIOLOGY TESTING
10.4.1 INFECTIOUS DISEASE TESTING
10.4.2 TRANSPLANT DIAGNOSTIC TESTING
10.4.3 OTHER MICROBIOLOGY TESTING
10.5 IMMUNOLOGY TESTING
10.6 DRUGS OF ABUSE TESTING
10.7 CYTOLOGY TESTING
10.8 GENETIC TESTING
11 MALAYSIA CLINICAL LABORATORY SERVICES MARKET, BY PROVIDER
11.1 OVERVIEW
11.2 HOSPITAL-BASED LABORATORIES
11.3 INDEPENDENT & REFERENCE LABORATORIES
11.4 NURSING AND PHYSICIAN OFFICE-BASED LABORATORIES
12 MALAYSIA CLINICAL LABORATORY SERVICES MARKET, BY APPLICATION
12.1 OVERVIEW
12.2 BIOANALYTICAL & LAB CHEMISTRY SERVICES
12.3 DRUG DEVELOPMENT RELATED SERVICES
12.4 DRUG DISCOVERY RELATED SERVICES
12.5 TOXICOLOGY TESTING SERVICES
12.6 CELL & GENE THERAPY RELATED SERVICES
12.7 PRECLINICAL & CLINICAL TRIAL RELATED SERVICES
12.8 OTHER CLINICAL LABORATORY SERVICES
13 MALAYSIA CLINICAL LABORATORY SERVICES MARKET, BY COUNTRY
13.1 MALAYSIA
14 THAILAND CLINICAL LABORATORY SERVICES MARKET, COMPANY LANDSCAPE
14.1 COMPANY SHARE ANALYSIS: MALAYSIA
15 SWOT ANALYSIS
16 COMPANY PROFILE
16.1 ABBOTT
16.1.1 COMPANY SNAPSHOT
16.1.2 REVENUE ANALYSIS
16.1.3 PRODUCT PORTFOLIO
16.1.4 RECENT DEVELOPMENTS
16.2 ANDALAB MEDICAL LABORATORIES
16.2.1 COMPANY SNAPSHOT
16.2.2 SERVICE PORTFOLIO
16.2.3 RECENT DEVELOPMENT
16.3 BRIANET
16.3.1 COMPANY SNAPSHOT
16.3.2 SERVICE PORTFOLIO
16.3.3 RECENT DEVELOPMENT
16.4 CHARLES RIVER LABORATORIES
16.4.1 COMPANY SNAPSHOT
16.4.2 RECENT FINANCIALS
16.4.3 PRODUCT PORTFOLIO
16.4.4 RECENT DEVELOPMENTS
16.5 CITO CLINICAL LABORATORY
16.5.1 COMPANY SNAPSHOT
16.5.2 SERVICE PORTFOLIO
16.5.3 RECENT DEVELOPMENTS
16.6 DAVITA INC.
16.6.1 COMPANY SNAPSHOT
16.6.2 RECENT FINANCIALS
16.6.3 PRODUCT PORTFOLIO
16.6.4 RECENT DEVELOPMENTS
16.7 EUROFINS SCIENTIFIC
16.7.1 COMPANY SNAPSHOT
16.7.2 RECENT FINANCIALS
16.7.3 SERVICE PORTFOLIO
16.7.4 RECENT DEVELOPMENTS
16.8 KERALTY
16.8.1 COMPANY SNAPSHOT
16.8.2 SERVICE PORTFOLIO
16.8.3 RECENT DEVELOPMENTS
16.9 LABSERV INC.
16.9.1 COMPANY SNAPSHOT
16.9.2 SERVICE PORTFOLIO
16.9.3 RECENT DEVELOPMENTS
16.1 LABORATORY CORPORATION OF AMERICA® HOLDINGS
16.10.1 COMPANY SNAPSHOT
16.10.2 REVENUE ANALYSIS
16.10.3 SERVICE PORTFOLIO
16.10.4 RECENT DEVELOPMENTS
16.11 MAYON CLINICAL LABORATORIES
16.11.1 COMPANY SNAPSHOT
16.11.2 SERVICE PORTFOLIO
16.11.3 RECENT DEVELOPMENT
16.12 MEDI LINX LABORATORY, INC.
16.12.1 COMPANY SNAPSHOT
16.12.2 SERVICE PORTFOLIO
16.12.3 RECENT DEVELOPMENTS
16.13 QUEST DIAGNOSTICS INCORPORATED
16.13.1 COMPANY SNAPSHOT
16.13.2 REVENUE ANALYSIS
16.13.3 SERVICE PORTFOLIO
16.13.4 RECENT DEVELOPMENTS
16.14 PARAHITA DIAGNOSTIC CENTER
16.14.1 COMPANY SNAPSHOT
16.14.2 SERVICE PORTFOLIO
16.14.3 RECENT DEVELOPMENT
16.15 PRODIA
16.15.1 COMPANY SNAPSHOT
16.15.2 REVENUE ANALYSIS
16.15.3 SERVICE PORTFOLIO
16.15.4 RECENT DEVELOPMENT
16.16 PT KIMIA FARMA DIAGNOSTIKA
16.16.1 COMPANY SNAPSHOT
16.16.2 SERVICE PORTFOLIO
16.16.3 RECENT DEVELOPMENT
16.17 SGS SA
16.17.1 COMPANY SNAPSHOT
16.17.2 REVENUE ANALYSIS
16.17.3 SERVICE PORTFOLIO
16.17.4 RECENT DEVELOPMENTS
16.18 SIEMENS HEALTHCARE GMBH
16.18.1 COMPANY SNAPSHOT
16.18.2 RECENT FINANCIALS
16.18.3 SERVICE PORTFOLIO
16.18.4 RECENT DEVELOPMENTS
16.19 SUNWAY MED LAB
16.19.1 COMPANY SNAPSHOT
16.19.2 SERVICE PORTFOLIO
16.19.3 RECENT DEVELOPMENT
16.2 SYNEOS HEALTH
16.20.1 COMPANY SNAPSHOT
16.20.2 REVENUE ANALYSIS
16.20.3 SERVICE PORTFOLIO
16.20.4 RECENT DEVELOPMENTS
17 QUESTIONNAIRE
18 RELATED REPORTS
Lista de Tabela
TABLE 1 TYPES AND RATES OF ERROR IN THE 3 STAGES OF THE LABORATORY TESTING PROCESS
TABLE 2 PRICE LIST OF VARIOUS HEMATOLOGY LABORATORY TESTINGS
TABLE 3 PRICE LIST OF VARIOUS SEROLOGY & IMMUNOLOGY LABORATORY TESTINGS
TABLE 4 MALAYSIA CLINICAL LABORATORY SERVICES MARKET, BY SERVICE TYPE, 2019-2028 (USD MILLION)
TABLE 5 MALAYSIA ROUTINE TESTING SERVICES IN CLINICAL LABORATORY SERVICES MARKET, BY SERVICE TYPE, 2019-2028 (USD MILLION)
TABLE 6 MALAYSIA ANATOMIC PATHOLOGY SERVICES IN CLINICAL LABORATORY SERVICES MARKET, BY SERVICE TYPE, 2019-2028 (USD MILLION)
TABLE 7 MALAYSIA CLINICAL LABORATORY SERVICES MARKET, BY SPECIALTY, 2019-2028 (USD MILLION)
TABLE 8 MALAYSIA CLINICAL CHEMISTRY TESTING IN CLINICAL LABORATORY SERVICES MARKET, BY SPECIALTY, 2019-2028 (USD MILLION)
TABLE 9 MALAYSIA HEMATOLOGY TESTING IN CLINICAL LABORATORY SERVICES MARKET, BY SPECIALTY, 2019-2028 (USD MILLION)
TABLE 10 MALAYSIA MICROBIOLOGY TESTING IN CLINICAL LABORATORY SERVICES MARKET, BY SPECIALTY, 2019-2028 (USD MILLION)
TABLE 11 MALAYSIA CLINICAL LABORATORY SERVICES MARKET, BY PROVIDER, 2019-2028 (USD MILLION)
TABLE 12 MALAYSIA CLINICAL LABORATORY SERVICES MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 13 MALAYSIA CLINICAL LABORATORY SERVICES MARKET, BY SERVICE TYPE, 2019-2028 (USD MILLION)
TABLE 14 MALAYSIA ROUTINE TESTING SERVICES IN CLINICAL LABORATORY SERVICES MARKET, BY SERVICE TYPE, 2019-2028 (USD MILLION)
TABLE 15 MALAYSIA ANATOMIC PATHOLOGY SERVICES IN CLINICAL LABORATORY SERVICES MARKET, BY SERVICE TYPE, 2019-2028 (USD MILLION)
TABLE 16 MALAYSIA CLINICAL LABORATORY SERVICES MARKET, BY SPECIALTY, 2019-2028 (USD MILLION)
TABLE 17 MALAYSIA CLINICAL CHEMISTRY TESTING IN CLINICAL LABORATORY SERVICES MARKET, BY SPECIALTY, 2019-2028 (USD MILLION)
TABLE 18 MALAYSIA MICROBIOLOGY TESTING IN CLINICAL LABORATORY SERVICES MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)
TABLE 19 MALAYSIA HEMATOLOGY TESTING IN CLINICAL LABORATORY SERVICES MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)
TABLE 20 MALAYSIA CLINICAL LABORATORY SERVICES MARKET, BY PROVIDER, 2019-2028 (USD MILLION)
TABLE 21 MALAYSIA CLINICAL LABORATORY SERVICES MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
Lista de Figura
FIGURE 1 MALAYSIA CLINICAL LABORATORY SERVICES MARKET SEGMENTATION
FIGURE 2 MALAYSIA CLINICAL LABORATORY SERVICES MARKET: DATA TRIANGULATION
FIGURE 3 MALAYSIA CLINICAL LABORATORY SERVICES MARKET: DROC ANALYSIS
FIGURE 4 MALAYSIA CLINICAL LABORATORY SERVICES MARKET: GLOBAL VS REGIONAL MARKET ANALYSIS
FIGURE 5 MALAYSIA CLINICAL LABORATORY SERVICES MARKET: COMPANY RESEARCH ANALYSIS
FIGURE 6 MALAYSIA CLINICAL LABORATORY SERVICES MARKET: INTERVIEW DEMOGRAPHICS
FIGURE 7 MALAYSIA CLINICAL LABORATORY SERVICES MARKET: DBMR MARKET POSITION GRID
FIGURE 8 MALAYSIA CLINICAL LABORATORY SERVICES MARKET SERVICE TYPE COVERAGE GRID
FIGURE 9 MALAYSIA CLINICAL LABORATORY SERVICES MARKET VENDOR SHARE ANALYSIS
FIGURE 10 MALAYSIA CLINICAL LABORATORY SERVICES MARKET SEGMENTATION
FIGURE 11 RISING INFECTIOUS DISEASES AND RISING DEMAND FOR EARLY AND ACCURATE DISEASE DIAGNOSIS ARE EXPECTED TO DRIVE THE GLOBAL CLINICAL LABORATORY SERVICES MARKET IN THE FORECAST PERIOD OF 2021 TO 2028
FIGURE 12 ROUTINE TESTING SERVICES SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE MALAYSIA CLINICAL LABORATORY SERVICES MARKET IN 2021 & 2028
FIGURE 13 REIMBURSEMENT POLICIES IN INDONESIA
FIGURE 14 DRIVERS, RESTRAINTS, OPPORTUNITIES AND CHALLENGES OF MALAYSIA CLINICAL LABORATORY SERVICES MARKET
FIGURE 15 BURDEN OF INFECTIOUS DISEASE IN SOUTHEAST ASIAN COUNTRIES
FIGURE 16 GROSS DOMESTIC PRODUCT (GDP) OF THE ASEAN COUNTRIES FROM 2000 TO 2018 (IN BILLION U.S. DOLLARS)
FIGURE 17 GDP PER CAPITA OF ASEAN COUNTRIES AS OF 2018
FIGURE 18 BENEFITS OF DIGITAL PATHOLOGY PLATFORMS
FIGURE 19 NUMBER OF COVID-19 TESTS IN SOUTHEAST ASIA AS OF 27 AUG, 2021
FIGURE 20 MALAYSIA CLINICAL LABORATORY SERVICES MARKET: BY SERVICE TYPE, 2020
FIGURE 21 MALAYSIA CLINICAL LABORATORY SERVICES MARKET: BY SERVICE TYPE, 2021-2028 (USD MILLION)
FIGURE 22 MALAYSIA CLINICAL LABORATORY SERVICES MARKET: BY SERVICE TYPE, CAGR (2021-2028)
FIGURE 23 MALAYSIA CLINICAL LABORATORY SERVICES MARKET: BY SERVICE TYPE, LIFELINE CURVE
FIGURE 24 MALAYSIA CLINICAL LABORATORY SERVICES MARKET: BY SPECIALTY, 2020
FIGURE 25 MALAYSIA CLINICAL LABORATORY SERVICES MARKET: BY SPECIALTY, 2021-2028 (USD MILLION)
FIGURE 26 MALAYSIA CLINICAL LABORATORY SERVICES MARKET: BY SPECIALTY, CAGR (2021-2028)
FIGURE 27 MALAYSIA CLINICAL LABORATORY SERVICES MARKET: BY SPECIALTY, LIFELINE CURVE
FIGURE 28 MALAYSIA CLINICAL LABORATORY SERVICES MARKET: BY PROVIDER, 2020
FIGURE 29 MALAYSIA CLINICAL LABORATORY SERVICES MARKET: BY PROVIDER, 2021-2028 (USD MILLION)
FIGURE 30 MALAYSIA CLINICAL LABORATORY SERVICES MARKET: BY PROVIDER, CAGR (2021-2028)
FIGURE 31 MALAYSIA CLINICAL LABORATORY SERVICES MARKET: BY PROVIDER, LIFELINE CURVE
FIGURE 32 MALAYSIA CLINICAL LABORATORY SERVICES MARKET: BY APPLICATION, 2020
FIGURE 33 MALAYSIA CLINICAL LABORATORY SERVICES MARKET: BY APPLICATION, 2021-2028 (USD MILLION)
FIGURE 34 MALAYSIA CLINICAL LABORATORY SERVICES MARKET: BY APPLICATION, CAGR (2021-2028)
FIGURE 35 MALAYSIA CLINICAL LABORATORY SERVICES MARKET: BY APPLICATION, LIFELINE CURVE
FIGURE 36 MALAYSIA CLINICAL LABORATORY SERVICES MARKET: COMPANY SHARE 2020 (%)
Metodologia de Investigação
A recolha de dados e a análise do ano base são feitas através de módulos de recolha de dados com amostras grandes. A etapa inclui a obtenção de informações de mercado ou dados relacionados através de diversas fontes e estratégias. Inclui examinar e planear antecipadamente todos os dados adquiridos no passado. Da mesma forma, envolve o exame de inconsistências de informação observadas em diferentes fontes de informação. Os dados de mercado são analisados e estimados utilizando modelos estatísticos e coerentes de mercado. Além disso, a análise da quota de mercado e a análise das principais tendências são os principais fatores de sucesso no relatório de mercado. Para saber mais, solicite uma chamada de analista ou abra a sua consulta.
A principal metodologia de investigação utilizada pela equipa de investigação do DBMR é a triangulação de dados que envolve a mineração de dados, a análise do impacto das variáveis de dados no mercado e a validação primária (especialista do setor). Os modelos de dados incluem grelha de posicionamento de fornecedores, análise da linha de tempo do mercado, visão geral e guia de mercado, grelha de posicionamento da empresa, análise de patentes, análise de preços, análise da quota de mercado da empresa, normas de medição, análise global versus regional e de participação dos fornecedores. Para saber mais sobre a metodologia de investigação, faça uma consulta para falar com os nossos especialistas do setor.
Personalização disponível
A Data Bridge Market Research é líder em investigação formativa avançada. Orgulhamo-nos de servir os nossos clientes novos e existentes com dados e análises que correspondem e atendem aos seus objetivos. O relatório pode ser personalizado para incluir análise de tendências de preços de marcas-alvo, compreensão do mercado para países adicionais (solicite a lista de países), dados de resultados de ensaios clínicos, revisão de literatura, mercado remodelado e análise de base de produtos . A análise de mercado dos concorrentes-alvo pode ser analisada desde análises baseadas em tecnologia até estratégias de carteira de mercado. Podemos adicionar quantos concorrentes necessitar de dados no formato e estilo de dados que procura. A nossa equipa de analistas também pode fornecer dados em tabelas dinâmicas de ficheiros Excel em bruto (livro de factos) ou pode ajudá-lo a criar apresentações a partir dos conjuntos de dados disponíveis no relatório.
